Pinion Investment Advisors LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Pinion Investment Advisors LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 630 shares of the biotechnology company’s stock, valued at approximately $374,000.

Several other institutional investors have also recently made changes to their positions in AXON. Nisa Investment Advisors LLC lifted its stake in Axon Enterprise by 6.3% during the third quarter. Nisa Investment Advisors LLC now owns 3,784 shares of the biotechnology company’s stock worth $1,512,000 after purchasing an additional 225 shares in the last quarter. US Bancorp DE boosted its stake in shares of Axon Enterprise by 2.3% in the third quarter. US Bancorp DE now owns 12,792 shares of the biotechnology company’s stock valued at $5,112,000 after purchasing an additional 284 shares during the period. Stephens Inc. AR grew its holdings in shares of Axon Enterprise by 4.9% in the third quarter. Stephens Inc. AR now owns 3,886 shares of the biotechnology company’s stock valued at $1,553,000 after purchasing an additional 181 shares in the last quarter. Gladstone Institutional Advisory LLC increased its stake in Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after buying an additional 26 shares during the period. Finally, Farther Finance Advisors LLC lifted its holdings in Axon Enterprise by 19.4% during the 3rd quarter. Farther Finance Advisors LLC now owns 875 shares of the biotechnology company’s stock worth $350,000 after buying an additional 142 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 0.5 %

NASDAQ AXON opened at $525.75 on Tuesday. The firm’s fifty day moving average price is $607.58 and its 200 day moving average price is $526.43. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $40.09 billion, a price-to-earnings ratio of 135.85, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05.

Analysts Set New Price Targets

Several equities analysts have commented on AXON shares. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price for the company. in a research note on Thursday, February 20th. TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Robert W. Baird boosted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Barclays set a $726.00 target price on shares of Axon Enterprise and gave the company an “overweight” rating in a report on Thursday. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $587.38.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 1,291 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total transaction of $829,377.13. Following the transaction, the president now owns 181,892 shares of the company’s stock, valued at $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares of the company’s stock, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,407 shares of company stock worth $4,122,925 over the last 90 days. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.